Nasser H. Hanna

机构：Indiana University School of Medicine, Indiana University – Purdue University Indianapolis · ORCID：0000-0002-7046-6426

发表论文 468 篇 · 总被引 16702 次 · h-index 59

代表论文

Randomized phase II study of consolidation immunotherapy with nivolumab and ipilimumab or nivolumab alone following concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small-cell lung cancer (NSCLC): Big Ten Cancer Research Consortium LUN16-081 (2025 · Journal for ImmunoTherapy of Cancer · 被引 9)
Evaluation of Radiation Pneumonitis in a Phase 2 Study of Consolidation Immunotherapy With Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation Therapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer (2024 · International Journal of Radiation Oncology*Biology*Physics · 被引 9)
Phase I/II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): Big ten cancer research consortium (BTCRC-LUN17-127) study (2024 · Lung Cancer · 被引 9)
Broadening the Net: Overcoming Challenges and Embracing Novel Technologies in Lung Cancer Screening (2025 · American Society of Clinical Oncology Educational Book · 被引 4)
Association of Immune-Related Adverse Events With Efficacy in Consolidation Nivolumab Plus Ipilimumab or Nivolumab Alone After Chemoradiation in Patients With Unresectable Stage III Nonsmall Cell Lung Cancer: An Exploratory Analysis From the Big 10 Cancer Research Consortium Study BTCRC LUN 16-081 (2024 · Clinical Lung Cancer · 被引 3)
TROP-2 expression in germ cell tumors (GCT). (2025 · Journal of Clinical Oncology · 被引 2)